The invention provides a method of activating hepatitis C virus (HCV)-specific T cells, including CD4.sup.+ and CD8.sup.+ T cells. HCV-specific T cells are activated using fusion proteins comprising HCV NS3, NS4, NS5a, and NS5b polypeptides, polynucleotides encoding such fusion proteins, or polypeptide or polynucleotide compositions containing the individual components of these fusions. The method can be used in model systems to develop HCV-specific immunogenic compositions, as well as to immunize a mammal against HCV.

 
Web www.patentalert.com

< Apparatus for the cultivation of immobilized micro-organisms

> Method for translating conditional expressions from a non-verilog hardware description language to verilog hardware description language while preserving structure suitable for logic synthesis
~ 00070